TrialJPEN. Journal of parenteral and enteral nutrition2021

Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance.

Marianne J Chapman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.